Patients suffering from chronic fatigue, brain fog, or stress-related memory issues often experience improvements after undergoing regular glutathione IV therapy
doi:10.1111/jdi.12450 59
The use of non-approved peptides or the use of approved peptides for conditions other than what they were approved for is known as "off-label" use
Diabetes Obes Metab 15(1):1527 Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
After two years, tirzepatide patients showed greater improvements in blood sugar control, weight, and waist circumference
Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks